Structure based design and in-Silico molecular docking analysis of some novel benzimidazoles

International Journal of ChemTech Research

Volumn 2, Issue 2, 2010, Pages

  Chhajed, S S ^a   Hiwanj, P B ^b   Bastikar, V A ^b   Upasani, C D ^c   Udavant, P B ^a   Dhake, A S ^a   Mahajan, N P ^d  

^a SMBT College of Pharmacy   (India)

^b Dr DY Patil Institute of Biotechnology and Bioinformatics   (India)

^c SSDJ College of Pharmacy   (India)

^d JUBILANT BIOSYS LTD   (India)

Author keywords

Benzimidazole; COX II; Molecular docking; Structure based design

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CELECOXIB; CYCLOOXYGENASE 2;

ARTICLE; COMPUTER MODEL; DRUG DESIGN; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; LIGAND BINDING; MOLECULAR DOCKING;

EID: 77954712600     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Labanauuskas, L.; Brukstus, A.; Udrenaite, E.; Gaidelis, P.; Bucinskaite, V. Chemija 2003, 14, 49;
2. Labanauuskas, L.; Brukstus, A.; Udrenaite, E.; Gaidelis, P.; Bucinskaite,V. Chem. Abstr. 2003, 139, 180016.
3. Kataev, V. A.; Khaliullin, A. N., Nasyrov, Kh. M.; Gailyunas, I. A. Russ. Patent RU 2215002, Chem. Abstr. 2004, 141, 7110.
4. Nakano, H.; Inoue, T.; Kawasaki, N.; Miyataka, H.; Matsumoto, H.; Taguchi, T.; Inagaki, N.; Nagai, H.;Satoh, T. Bioorg. Med. Chem. 2000, 8, 373.
5. Hong, S.-Y.; Chung, K.-H.; You, H.-J.; Choi, I. H.; Chae, M. J.; Han, J.-Y.; Jung, O.-K.; Kang, S.-J.; Ryu, C.-K. Bioorg. Med. Chem. Lett. 2004, 14, 3563.
6. Garuti, L.; Roberti, M.; Pizzirani, D.; Pession, A.; Leoncini, E.; Cenci, V.; Hrelia, S. IL Farmaco 2004, 59, 663.
7. White, A. W.; Curtin, N. J.; Eastman, B. W.; Golding, B. T.; Hostomsky, Z.; Kyle, S.; Li, J.; Maegley, K. A.; Skalitzky, D. J.; Webber, S. E.; Yu, X.-H.; Griffin, R. J. Bioorg. Med. Chem. Lett. 2004, 14, 2433.
8. Novelli, F.; Tasso, B.; Sparatore, F.; Sparatore, A. Farmaco 1997, 52, 499;.
9. Novelli, F.; Tasso, B.; Sparatore, F.; Sparatore, A. Chem. Abstr. 1998, 128, 238983j.
10. Kazimierczuk, Z.; Andrzejewska, M.; Kaustova, J.; Klimesova, V. Eur. J. Med. Chem. 2005, 40, 203.
11. Marnett, L. J. and A. S. Kalgutkar (1999). Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends in Pharmacological Sciences 20(11): 465-469. doi:10.1016/S0165-6147(99)01385-1.
12. Mardini, I. A. and G. A. FitzGerald (2001). Selective Inhibitors of Cyclooxygenase-2: A Growing Class of Anti-Inflammatory Drugs. Mol. Interv. 1(1): 30-38.
13. Marnett, L. J. and A. S. Kalgutkar (1998). Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. Current Opinion in Chemical Biology 2(4): 482-490. doi:10.1016/S1367-5931(98)80124-5.
14. King, F. D., Ed. (2002). Medicinal chemistry Principles and practice. Cambridge, The royal Society of Chemistry.
15. Llorens, O., J. J. Perez, et al. (1999). Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase. Bio. & Med. Chem. Let. 9(19): 2779-2784. doi:10.1016/S0960- 894X(99)00481-3.